Edition:
India

Haemonetics Corp (HAE.N)

HAE.N on New York Stock Exchange

27.77USD
24 May 2016
Change (% chg)

$0.27 (+0.98%)
Prev Close
$27.50
Open
$27.62
Day's High
$27.84
Day's Low
$27.52
Volume
5,053
Avg. Vol
117,270
52-wk High
$43.85
52-wk Low
$25.98

HAE.N

Chart for HAE.N

About

Haemonetics Corporation is a healthcare company, which provides blood management solutions to its customers. The Company's portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain. It serves three customer segments: manufacturers... (more)

Overall

Beta: 0.83
Market Cap(Mil.): $1,398.31
Shares Outstanding(Mil.): 50.85
Dividend: --
Yield (%): --

Financials

BRIEF-Haemonetics plans repositioning organization, reduce number of employees

* On may 6, 2016, co committed to a plan for repositioning organization and cost structure; this involves reduction in number of employees

10 May 2016

BRIEF-Haemonetics Corp announces Christopher Simon as CEO

* Haemonetics corporation announces Christopher Simon as president and chief executive officer

10 May 2016

BRIEF-Haemonetics Corp sees FY 2017 adjusted earnings per share $1.40-$1.50

* FY2017 earnings per share view $1.55, revenue view $911.3 million -- Thomson Reuters I/B/E/S

10 May 2016

BRIEF-Haemonetics Q4 GAAP loss per share $0.17

* Haemonetics reports 4th quarter fiscal 2016 revenue of $243 million, constant currency revenue growth of 10% and 7% as reported; fiscal 2016 revenue of $910 million, constant currency revenue growth of 3% and flat as reported

02 May 2016

Competitors

Earnings vs. Estimates